Atlas Trials

Effectiveness and Safety of Palbociclib: Brand vs. Generic in Iraqi Stage IV Breast Cancer Patients

Clinical trial NCT07493291 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07493291
Sponsor
Al-Mustansiriyah University
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Brest CancerCDK4/6 Inhibitor
Start date
2025-09-07
Primary completion
2026-03-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.